Hidehiro Ishii
Impact in
- Ophthalmology top 1%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
Papers in
-
- Metabolism, Diabetes, and Cancer 5
-
- Diabetes Treatment and Management 5
- Co-authors
- George L. King (4 shared papers)Daisuke Koya (2 shared papers)Chikako Takagi (2 shared papers)Kirk Ways (1 shared paper)Michael R. Jirousek (1 shared paper)Thomas A. Ciulla (1 shared paper)Fumi Mori (1 shared paper)Elia J. Duh (1 shared paper)
- Journals
- Diabetes (2 papers)Journal of Molecular Medicine (2 papers)Journal of Clinical Investigation (1 paper)Endocrine Journal (1 paper)Internal Medicine (1 paper)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hidehiro Ishii
17 papers receiving 1.4k citations
Hidehiro Ishii's Hit Papers
Peers
Comparison fields: 5 of 81
- Ophthalmology 454
- Clinical Biochemistry 284
- Neurology 117
- Endocrinology, Diabetes and Metabolism 235
- Nephrology 88
Countries citing papers authored by Hidehiro Ishii
This map shows the geographic impact of Hidehiro Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidehiro Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidehiro Ishii more than expected).
Fields of papers citing papers by Hidehiro Ishii
This network shows the impact of papers produced by Hidehiro Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidehiro Ishii. The network helps show where Hidehiro Ishii may publish in the future.
Co-authors
The 25 scholars most cited alongside Hidehiro Ishii, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor Hit paper breakdown → | 1997 | 515 |
| 2 | 1999 | 343 | |
| 3 | 1997 | 219 | |
| 4 | 1998 | 163 | |
| 5 | Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. | 1997 | 68 |
| 6 | 1990 | 37 | |
| 7 | 1992 | 33 | |
| 8 | 2000 | 18 | |
| 9 | Platelet-derived growth factor and growth-promoting activity in the serum samples and platelets of patients with non-insulin-dependent diabetes mellitus. | 1992 | 10 |
| 10 | 1991 | 9 | |
| 11 | 2018 | 3 | |
| 12 | 1989 | 2 | |
| 13 | Secondary Failure of Troglitazone in Type 2 Diabetic Patients and its Predictive Factors | 2001 | 1 |
| 14 | 1988 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 1989 | 1 | |
| 18 | 1992 | 1 | |
| 19 | 2026 | 0 | |
| 20 | 2023 | 0 |
About Hidehiro Ishii
Hidehiro Ishii is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery, Epidemiology and Physiology, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (5 papers), Diabetes Treatment and Management (5 papers), Diabetes and associated disorders (3 papers), Retinal Diseases and Treatments (3 papers), Pancreatic function and diabetes (2 papers), Advanced Glycation End Products research (2 papers), Infectious Diseases and Tuberculosis (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). The work is most often cited by research in Ophthalmology (454 citations), Clinical Biochemistry (284 citations), Neurology (117 citations), Endocrinology, Diabetes and Metabolism (235 citations) and Nephrology (88 citations). Hidehiro Ishii has collaborated with scholars based in Japan, United States and China. Frequent co-authors include George L. King, Daisuke Koya, Chikako Takagi, Kirk Ways, Michael R. Jirousek, Thomas A. Ciulla, Fumi Mori, Elia J. Duh, Lois E. H. Smith and Allen C. Clermont. Their work appears in journals such as Diabetes, Journal of Molecular Medicine, Journal of Clinical Investigation, Endocrine Journal and Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.